On Thursday, Eli Lilly and Co (NYSE:LLY)’s shares declined -0.42% to $83.03.
Eli Lilly and Company (LLY) has accepted the recommendation of the ACCELERATE study data monitoring committee to continue the Phase 3 trial of the investigational medicine evacetrapib, based on data from an interim futility analysis.
Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. It operates in two segments, Human Pharmaceutical Products and Animal Health products. The company offers endocrinology products to treat diabetes; osteoporosis in postmenopausal women and men; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency.
Spirit Airlines Incorporated (NASDAQ:SAVE)’s shares dropped -0.96% to $59.96.
Vegas Baby!!! Those two words can right away improve the gloomiest of moods. Flying to Vegas with more money in your pocket makes you a winner even before you hit the slots or shows. Now flying nonstop to Vegas from NOLA just got a whole lot cheaper because Spirit Airlines has declared daily, nonstop service to and from Louis Armstrong New Orleans International (MSY) and McCarran International Airport (LAS) in Las Vegas. So people in the Big Easy can now get Big Savings while gettin’ their Vegas on!
This new daily service starts on November 13, 2015 and brings the total number of Spirit nonstop flights to six destinations from New Orleans counting Chicago, Ft. Lauderdale/Miami, Houston, Dallas, and Detroit. Spirit operates 28 daily departures to 19 destinations from Las Vegas.
Spirit Airlines, Inc. provides low-fare airline services. As of June 30, 2015, it operated about 360 daily flights to 57 destinations in the United States, Caribbean, and Latin America. As of December 31, 2014, the company had a fleet of 65 Airbus single-aisle aircraft comprising 29 A319s, 34 A320s, and 2 A321s. Spirit Airlines, Inc. was founded in 1964 and is headquartered in Miramar, Florida.
At the end of Thursday’s trade, MedAssets, Inc. (NASDAQ:MDAS)‘s shares dipped -0.47% to $21.11.
MedAssets (MDAS) declared that it has broadened its purchased services approach through an exclusive partnership with Valify to offer a new web-based analytics solution designed to standardize purchased services spend across the health system enterprise. The expansion of MedAssets Purchased Services Solutions capabilities to comprise new data and analytics software will complement its unique set of consulting services and solutions that support the administration of non-medical and operational spend to further identify and analyze top areas of cost reduction.
MedAssets, Inc., a performance improvement company, provides technology-enabled products and services for hospitals, health systems, non-acute healthcare providers, payers, and other service providers and product manufacturers in the United States. It operates in two segments, Spend and Clinical Resource Administration (SCM) and Revenue Cycle Administration (RCM). The SCM segment provides a suite of cost administration services, supply chain analytics, and data capabilities; planned sourcing and group purchasing services; and medical device and clinical resource consulting, lean performance improvement, workforce administration, and supply chain outsourcing and procurement services.
Acadia Healthcare Company Inc (NASDAQ:ACHC), ended its Thursday’s trading session with 0.38% gain, and closed at $80.68.
Acadia Healthcare Company, Inc. (ACHC) declared financial results for the second quarter and six months ended June 30, 2015. For the quarter, revenue raised 112.2% to $453.7 million from $213.8 million for the second quarter of 2014. Income from ongoing operations was $33.8 million, or $0.49 per diluted share, for the second quarter of 2015 contrast with $22.5 million, or $0.43 per diluted share, for the second quarter of 2014. Adjusted income from ongoing operations raised 137.8% to $39.5 million for the second quarter of 2015 from $16.6 million for the second quarter of 2014, while adjusted income from ongoing operations per diluted share raised 78.1% to $0.57 from $0.32. The adjusted results exclude transaction-related expenses of $7.2 million and $3.0 million for the second quarter of 2015 and 2014, respectively, a $1.0 million loss on foreign currency derivatives for the second quarter of 2015 and a $13.7 million gain on foreign currency derivatives for the second quarter of 2014. Weighted average shares outstanding raised 32.6% for the second quarter of 2015 from the second quarter of 2014, primarily due to the issuance of common stock in June 2014 and February and May 2015, the net proceeds of which have primarily been used to fund acquisitions. A reconciliation of all non-GAAP financial results in this release appears on pages 8 and 9.
Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, and substance abuse facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.